{"id":408594,"date":"2021-01-05T09:03:29","date_gmt":"2021-01-05T14:03:29","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=408594"},"modified":"2021-01-05T09:03:29","modified_gmt":"2021-01-05T14:03:29","slug":"marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/","title":{"rendered":"Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered"},"content":{"rendered":"
\n

\n DAVIS, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — <\/strong>Marrone Bio Innovations, Inc. (NASDAQ:\u00a0MBII), a leading provider of effective and environmentally responsible pest management and plant health products, today provided an update on its warrant transactions.<\/p>\n

Effective Dec. 29, 2020, an amendment was made to a prior warrant agreement with Van Herk Investments that extends the maturities of its existing warrants. As a result, Van Herk exercised 33.3% of its outstanding warrants, reducing the total number of its outstanding warrants, and providing $1.7 million in funds to Marrone Bio.<\/p>\n

\u201cWith this warrant amendment, our prior warrant restructurings and recent warrant exercises and expirations, only 27.6% percent of the total warrants outstanding at the beginning of 2020 are currently outstanding. Assuming full cash exercise of remaining warrants from our restructuring transactions, we would receive $6.2 million in the first quarter and $5.5 million in the fourth quarter of 2021,\u201d said Chief Executive Officer Kevin Helash. \u201cOur warrant overhang will be essentially removed by the end of this year.\u201d<\/p>\n

\u201cThese warrant transactions have provided financial and timing flexibility to the company that allows us to pursue strategic alternatives to strengthen our position as the leader in agricultural biological solutions,\u201d Helash added.<\/p>\n

\n About Marrone Bio Innovations<\/strong>\n <\/p>\n

\n
\n Marrone Bio Innovations Inc.<\/a>
\n <\/u>\u00a0(NASDAQ: MBII) is a growth-oriented company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 400 issued and pending patents, MBI\u2019s currently available commercial products are Regalia\u00ae, Stargus\u00ae, Grandevo\u00ae, Venerate\u00ae, Majestene\u00ae, Haven\u00ae, Pacesetter\u2122, Zelto\u00ae Jet Oxide\u00ae and Jet Ag\u00ae and Zequanox\u00ae, with a next-generation insecticide-nematicide, a breakthrough bioherbicide and a biofumigant in the Company\u2019s product pipeline. MBI\u2019s Pro Farm Finland-based subsidiary employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality. Products include UBP\u2122 110, Foramin\u00ae, UBP\u2122 Seed Treatment, Foramin\u00ae ST.<\/p>\n

Learn more about Marrone Bio Innovations at\u00a0www.marronebio.com<\/a><\/u>. We also use our investor relations website,\u00a0https:\/\/investors.marronebio.com<\/a><\/u>, as well as our corporate Twitter account, @Marronebio, as means of disclosing material non-public information, and encourage our investors and others to monitor and review the information we make public in these locations. Follow us on social media:\u00a0Twitter<\/a><\/u>,\u00a0LinkedIn<\/a><\/u>\u00a0and\u00a0Instagram<\/a><\/u>.<\/p>\n

\n Marrone Bio Innovations Forward Looking Statements<\/strong>\n <\/p>\n

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI\u2019s views as of any subsequent date. Examples of such statements include statements regarding the potential exercise of warrants and use of proceeds, including for strategic alternatives. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company\u2019s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including consumer, regulatory and other factors affecting demand for the Company\u2019s products, any difficulty in marketing MBI\u2019s products in global markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers, and adverse decisions by regulatory agencies and other relevant third parties. Additional information that could lead to material changes in MBI\u2019s performance is contained in its filings with the Securities and Exchange Commission. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.<\/p>\n

\n Marrone Bio Innovations Contacts:<\/strong>
\n
Kevin Helash, CEO
Jim Boyd, President and CFO
Clyde Montevirgen, IR
Telephone: +1 (530) 750-2800
Email:\u00a0Info@marronebio.com<\/a><\/u><\/p>\n

\n Investor Relations Contact:<\/strong>
\n
Lucas A. Zimmerman
Senior Vice President
MZ Group \u2013 MZ North America
Main: 949-259-4987
MBII@mzgroup.us
<\/a><\/u>www.mzgroup.us<\/a><\/u><\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

DAVIS, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ:\u00a0MBII), a leading provider of effective and environmentally responsible pest management and plant health products, today provided an update on its warrant transactions. Effective Dec. 29, 2020, an amendment was made to a prior warrant agreement with Van Herk Investments that extends the maturities of its existing warrants. As a result, Van Herk exercised 33.3% of its outstanding warrants, reducing the total number of its outstanding warrants, and providing $1.7 million in funds to Marrone Bio. \u201cWith this warrant amendment, our prior warrant restructurings and recent warrant exercises and expirations, only 27.6% percent of the total warrants outstanding at the beginning of 2020 are currently outstanding. Assuming full … <\/p>\n

Continue reading “Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-408594","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMarrone Bio Provides Update on Warrant Transactions; No New Securities Offered - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DAVIS, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ:\u00a0MBII), a leading provider of effective and environmentally responsible pest management and plant health products, today provided an update on its warrant transactions. Effective Dec. 29, 2020, an amendment was made to a prior warrant agreement with Van Herk Investments that extends the maturities of its existing warrants. As a result, Van Herk exercised 33.3% of its outstanding warrants, reducing the total number of its outstanding warrants, and providing $1.7 million in funds to Marrone Bio. \u201cWith this warrant amendment, our prior warrant restructurings and recent warrant exercises and expirations, only 27.6% percent of the total warrants outstanding at the beginning of 2020 are currently outstanding. Assuming full … Continue reading "Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-05T14:03:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQwNSMzOTA0MjE2IzIwMjc4OTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered\",\"datePublished\":\"2021-01-05T14:03:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\\\/\"},\"wordCount\":714,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDQwNSMzOTA0MjE2IzIwMjc4OTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\\\/\",\"name\":\"Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDQwNSMzOTA0MjE2IzIwMjc4OTM=\",\"datePublished\":\"2021-01-05T14:03:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDQwNSMzOTA0MjE2IzIwMjc4OTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDQwNSMzOTA0MjE2IzIwMjc4OTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/","og_locale":"en_US","og_type":"article","og_title":"Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered - Market Newsdesk","og_description":"DAVIS, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ:\u00a0MBII), a leading provider of effective and environmentally responsible pest management and plant health products, today provided an update on its warrant transactions. Effective Dec. 29, 2020, an amendment was made to a prior warrant agreement with Van Herk Investments that extends the maturities of its existing warrants. As a result, Van Herk exercised 33.3% of its outstanding warrants, reducing the total number of its outstanding warrants, and providing $1.7 million in funds to Marrone Bio. \u201cWith this warrant amendment, our prior warrant restructurings and recent warrant exercises and expirations, only 27.6% percent of the total warrants outstanding at the beginning of 2020 are currently outstanding. Assuming full … Continue reading \"Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-05T14:03:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQwNSMzOTA0MjE2IzIwMjc4OTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered","datePublished":"2021-01-05T14:03:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/"},"wordCount":714,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQwNSMzOTA0MjE2IzIwMjc4OTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/","name":"Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQwNSMzOTA0MjE2IzIwMjc4OTM=","datePublished":"2021-01-05T14:03:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQwNSMzOTA0MjE2IzIwMjc4OTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQwNSMzOTA0MjE2IzIwMjc4OTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marrone-bio-provides-update-on-warrant-transactions-no-new-securities-offered\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=408594"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408594\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=408594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=408594"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=408594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}